Latest Breaking News On - John claude saltiel - Page 1 : comparemela.com

Share this article Share this article ATLANTA, May 11, 2021 /PRNewswire/  NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to treat the devastating effects of acquired brain injury, today announced it has entered into a research collaboration with Antwerp University Hospital, Belgium, to help support Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI), a prospective longitudinal observational study that is collecting clinical and epidemiological data to identify the most effective clinical care and treatment recommendations, develop and validate surrogate biomarkers of injury and recovery, and improve the classification of traumatic brain injury (TBI) to enable targeted therapies.

United statesUnited kingdomJohn claude saltielCarl longSusan pietropaoloDavidk menonCenters for diseaseUs department of defenseEuropean commissionBrain injury programNeurotrauma sciencesUniversity of cambridgeWolfson brain imaging centreInternational initiative for traumatic brain injury researchCorporate developmentUs national institutes of health